Session R.A. II's Form 4 filing
Taysha Gene Therapies, Inc. (TSHA) · filed Jul 14, 2023
- Accession no.
- 0000950170-23-032986
- Filed
- Jul 14, 2023
- Trade date
- Jul 12-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $60.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Session R.A. IICIK 0001701846 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2023 | Common Stock | SSaleDisposed | −80,528 | $0.71 | −$57,174.88 | 8,877,091 | Direct | |
| Jul 13, 2023 | Common Stock | SSaleDisposed | −5,344 | $0.70 | −$3,740.8 | 8,871,747 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.